menu
    • menu

    Company profile for Avanthera SA

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AVANTHERA is a privately held, Swiss company dedicated to the development and manufacturing of advanced therapeutic ingredients using complex chemistry. As a contract research and manufacturing organization (CRO and CMO), AVANTHERA has built a sound supply chain and manufacturing network worldwide. We manage the project along the entire supply chain to the API using advanced technologies for special product classes such as HP...
    AVANTHERA is a privately held, Swiss company dedicated to the development and manufacturing of advanced therapeutic ingredients using complex chemistry. As a contract research and manufacturing organization (CRO and CMO), AVANTHERA has built a sound supply chain and manufacturing network worldwide. We manage the project along the entire supply chain to the API using advanced technologies for special product classes such as HPAI’s (highly potent active ingredients), oncology APIs, steroids, prostaglandins and their advanced intermediates.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Avanthera SASwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Via Pizzamiglio 126833 Vacallo
    Telephone
    Telephone
    + 41 91 986 60 10
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://avanthera.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Reviewing Anthera Pharmaceuticals (ANTH) & Concert Pharmaceuticals (CNCE)
    Reviewing Anthera Pharmaceuticals (ANTH) & Concert Pharmaceuticals (CNCE)

    25 Jul 2018

    // FAIRFIELDCURRENT

    https://www.fairfieldcurrent.com/2018/07/25/reviewing-anthera-pharmaceuticals-anth-concert-pharmaceuticals-cnce.html

    FAIRFIELDCURRENT
    25 Jul 2018
    Share Share
    Anthera Announces Presentation of Blisibimod Lupus Research - American Society
    Anthera Announces Presentation of Blisibimod Lupus Research - American Society

    01 Nov 2017

    // GLOBENEWSWIRE

    https://globenewswire.com/news-release/2017/11/01/1172662/0/en/Anthera-Pharmaceuticals-Announces-Presentation-of-Blisibimod-Lupus-Research-at-the-American-Society-of-Nephrology-Annual-Meeting.html

    GLOBENEWSWIRE
    01 Nov 2017
    Share Share
    AntheraPharma Announces RESULT Phase 3 Clinical Study of Sollpura
    AntheraPharma Announces RESULT Phase 3 Clinical Study of Sollpura

    14 Aug 2017

    // BGLOBENEWSWIRE

    https://globenewswire.com/news-release/2017/08/14/1084291/0/en/Anthera-Pharmaceuticals-Announces-RESULT-Phase-3-Clinical-Study-of-Sollpura-will-be-Included-in-the-European-Cystic-Fibrosis-Clinical-Trial-Network.html

    BGLOBENEWSWIRE
    14 Aug 2017
    Share Share
    Anthera Announces FDA Orphan Drug Designation for Blisibimod for-IgA Nephropathy
    Anthera Announces FDA Orphan Drug Designation for Blisibimod for-IgA Nephropathy

    09 Aug 2017

    // GLOBENEWSWIRE

    https://globenewswire.com/news-release/2017/08/09/1082711/0/en/Anthera-Announces-FDA-Orphan-Drug-Designation-for-Blisibimod-for-the-Treatment-of-IgA-Nephropathy.html

    GLOBENEWSWIRE
    09 Aug 2017
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search